JP2011529033A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011529033A5 JP2011529033A5 JP2011519189A JP2011519189A JP2011529033A5 JP 2011529033 A5 JP2011529033 A5 JP 2011529033A5 JP 2011519189 A JP2011519189 A JP 2011519189A JP 2011519189 A JP2011519189 A JP 2011519189A JP 2011529033 A5 JP2011529033 A5 JP 2011529033A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pyridin
- mol
- added
- prostate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13592008P | 2008-07-25 | 2008-07-25 | |
| US61/135,920 | 2008-07-25 | ||
| US22068509P | 2009-06-26 | 2009-06-26 | |
| US61/220,685 | 2009-06-26 | ||
| PCT/EP2009/059605 WO2010010191A1 (en) | 2008-07-25 | 2009-07-24 | Novel compounds useful for the treatment of degenerative and inflammatory diseases. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011529033A JP2011529033A (ja) | 2011-12-01 |
| JP2011529033A5 true JP2011529033A5 (https=) | 2012-09-06 |
| JP5480261B2 JP5480261B2 (ja) | 2014-04-23 |
Family
ID=41021059
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011519189A Active JP5480261B2 (ja) | 2008-07-25 | 2009-07-24 | 変性及び炎症性疾患の治療に有用な新規化合物 |
| JP2011519188A Active JP5559168B2 (ja) | 2008-07-25 | 2009-07-24 | 変性及び炎症性疾患の治療に有用な新規化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011519188A Active JP5559168B2 (ja) | 2008-07-25 | 2009-07-24 | 変性及び炎症性疾患の治療に有用な新規化合物 |
Country Status (35)
| Country | Link |
|---|---|
| US (5) | US8853240B2 (https=) |
| EP (2) | EP2361251B1 (https=) |
| JP (2) | JP5480261B2 (https=) |
| KR (2) | KR101676391B1 (https=) |
| CN (2) | CN102105472B (https=) |
| AR (1) | AR072875A1 (https=) |
| AU (2) | AU2009273144B2 (https=) |
| BR (2) | BRPI0916659B8 (https=) |
| CA (2) | CA2730762C (https=) |
| CL (1) | CL2009001637A1 (https=) |
| CO (1) | CO6361925A2 (https=) |
| CR (1) | CR20110092A (https=) |
| CY (2) | CY1113945T1 (https=) |
| DK (2) | DK2361251T3 (https=) |
| DO (1) | DOP2011000022A (https=) |
| EA (2) | EA018587B1 (https=) |
| ES (2) | ES2406691T3 (https=) |
| HR (2) | HRP20140681T1 (https=) |
| IL (2) | IL210261A (https=) |
| JO (1) | JO3041B1 (https=) |
| MA (1) | MA32551B1 (https=) |
| ME (1) | ME02046B (https=) |
| MX (2) | MX2011000756A (https=) |
| MY (1) | MY157615A (https=) |
| NZ (1) | NZ590646A (https=) |
| PE (1) | PE20100152A1 (https=) |
| PL (2) | PL2346864T3 (https=) |
| PT (2) | PT2346864E (https=) |
| RS (2) | RS52823B (https=) |
| SI (2) | SI2361251T1 (https=) |
| SM (2) | SMT201300051B (https=) |
| TW (1) | TWI447118B (https=) |
| UY (1) | UY32006A (https=) |
| WO (2) | WO2010010191A1 (https=) |
| ZA (2) | ZA201100396B (https=) |
Families Citing this family (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| JO3041B1 (ar) | 2008-07-25 | 2016-09-05 | Galapagos Nv | مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية |
| CN102459258B (zh) | 2009-06-05 | 2015-11-25 | 赛福伦公司 | 1,2,4-三唑并[1,5a]吡啶衍生物的制备和用途 |
| TWI462920B (zh) * | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| US20100331222A1 (en) * | 2009-06-26 | 2010-12-30 | Basf Se | Process for producing cellulose beads from solutions of cellulose in ionic liquid |
| JO3030B1 (ar) * | 2009-06-26 | 2016-09-05 | Galapagos Nv | مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات |
| WO2011140333A1 (en) | 2010-05-07 | 2011-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Identification of stabilizers of multimeric proteins |
| EP2588105A1 (en) | 2010-07-01 | 2013-05-08 | Cellzome Limited | Triazolopyridines as tyk2 inhibitors |
| AR086042A1 (es) * | 2011-04-28 | 2013-11-13 | Galapagos Nv | Compuesto util para el tratamiento de enfermedades degenerativas e inflamatorias y composicion farmaceutica |
| JP6280546B2 (ja) | 2012-06-26 | 2018-02-14 | デル マー ファーマシューティカルズ | ジアンヒドロガラクチトール、ジアセチルジアンヒドロガラクチトール、ジブロモズルシトール、又はこれらの類似体若しくは誘導体を用いた、遺伝子多型又はａｈｉ１の調節不全若しくは変異を有する患者におけるチロシンキナーゼインヒビター抵抗性悪性腫瘍を処置するための方法 |
| US9169214B2 (en) | 2012-12-21 | 2015-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions |
| CN103965114B (zh) * | 2013-01-28 | 2016-01-06 | 苏州泽璟生物制药有限公司 | 氘代的苯基氨基嘧啶化合物以及包含该化合物的药物组合物 |
| EP2951590A1 (en) | 2013-02-04 | 2015-12-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for assaying jak2 activity in red blood cells and uses thereof |
| EP3010922B1 (en) * | 2013-06-19 | 2017-03-15 | Galapagos NV | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| MX368464B (es) | 2013-12-05 | 2019-10-02 | Pfizer | Acrilamidas de pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinil o y pirrolo[2,3-d]piridinilo. |
| AU2014368945C1 (en) | 2013-12-20 | 2019-05-16 | Sagimet Biosciences Inc. | Heterocyclic modulators of lipid synthesis and combinations thereof |
| GB201402071D0 (en) * | 2014-02-07 | 2014-03-26 | Galapagos Nv | Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201402070D0 (en) * | 2014-02-07 | 2014-03-26 | Galapagos Nv | Pharmaceutical compositions for the treatment of inflammatory disorders |
| US20160045609A1 (en) | 2014-08-14 | 2016-02-18 | Mamoun M. Alhamadsheh | Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life |
| TWI679205B (zh) | 2014-09-02 | 2019-12-11 | 日商日本新藥股份有限公司 | 吡唑并噻唑化合物及醫藥 |
| WO2016119700A1 (en) | 2015-01-28 | 2016-08-04 | Jn Therapeutics | Substituted imidazo [1, 2-a] pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof |
| CA2982630A1 (en) * | 2015-04-13 | 2016-10-20 | Galapagos Nv | Methods for the treatment of inflammatory disorders |
| ES2734048T3 (es) * | 2015-04-29 | 2019-12-04 | Wuxi Fortune Pharmaceutical Co Ltd | Inhibidores de Janus cinasas (JAK) |
| WO2016179207A1 (en) * | 2015-05-05 | 2016-11-10 | Concert Pharmaceuticals, Inc. | Deuterated filgotinib |
| CN105061420B (zh) * | 2015-06-04 | 2017-09-05 | 南京旗昌医药科技有限公司 | 一种jak抑制剂的晶型及其制备方法和应用 |
| CN104987333B (zh) * | 2015-07-14 | 2017-01-11 | 苏州富士莱医药股份有限公司 | 一种Filgotinib的合成方法 |
| WO2017012770A1 (en) | 2015-07-23 | 2017-01-26 | Ratiopharm Gmbh | Acid addition salts of filgotinib |
| WO2017012771A1 (en) | 2015-07-23 | 2017-01-26 | Ratiopharm Gmbh | Crystalline filgotinib sulfonic acid addition salts |
| WO2017012773A1 (en) | 2015-07-23 | 2017-01-26 | Ratiopharm Gmbh | Solid forms of filgotinib free base |
| CN105198879B (zh) * | 2015-09-18 | 2017-09-22 | 上海宣创生物科技有限公司 | 一种环丙烷甲酰胺衍生物c晶型及其制备方法 |
| CN105111207B (zh) * | 2015-09-18 | 2017-07-25 | 上海宣创生物科技有限公司 | 一种环丙烷甲酰胺衍生物d晶型及其制备方法 |
| CN105218539B (zh) * | 2015-09-18 | 2017-07-25 | 上海宣创生物科技有限公司 | 一种环丙烷甲酰胺衍生物b晶型及其制备方法 |
| CN105198880B (zh) * | 2015-09-18 | 2017-07-25 | 上海宣创生物科技有限公司 | 一种环丙烷甲酰胺衍生物a晶型及其制备方法 |
| CN105198877B (zh) * | 2015-09-18 | 2017-09-22 | 上海宣创生物科技有限公司 | 一种环丙烷甲酰胺衍生物g晶型及其制备方法 |
| CN105198876B (zh) * | 2015-09-18 | 2017-09-29 | 上海宣创生物科技有限公司 | 一种环丙烷甲酰胺衍生物h晶型及其制备方法 |
| CN105198878B (zh) * | 2015-09-18 | 2017-07-25 | 上海宣创生物科技有限公司 | 一种环丙烷甲酰胺衍生物f晶型及其制备方法 |
| CN105111206B (zh) * | 2015-09-18 | 2017-07-25 | 上海宣创生物科技有限公司 | 一种环丙烷甲酰胺衍生物e晶型及其制备方法 |
| WO2017133423A1 (zh) * | 2016-02-02 | 2017-08-10 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的吡啶酰胺类化合物及其应用 |
| TWI712604B (zh) | 2016-03-01 | 2020-12-11 | 日商日本新藥股份有限公司 | 具jak抑制作用之化合物之結晶 |
| JP6978097B2 (ja) * | 2016-07-26 | 2021-12-08 | スーヂョウ ロングバイオテック ファーマシューティカルズ カンパニー リミテッドSuzhou Longbiotech Pharmaceuticals Co., Ltd. | Ｊａｋ阻害剤としての複素環化合物、該化合物の塩類および治療への使用 |
| JOP20190024A1 (ar) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
| CN107880038B (zh) * | 2016-09-30 | 2021-09-28 | 中国医药研究开发中心有限公司 | [1,2,4]三唑并[1,5-a]吡啶类化合物及其制备方法和医药用途 |
| TWI752098B (zh) * | 2016-10-10 | 2022-01-11 | 美商亞雷生物製藥股份有限公司 | 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
| EP3532477B1 (en) * | 2016-10-26 | 2020-08-26 | Janssen Pharmaceutica NV | Fused bicylic pyridine compounds and their use as ampa receptor modulators |
| JP6994029B2 (ja) * | 2016-10-26 | 2022-01-14 | ヤンセン ファーマシューティカ エヌ．ベー． | 融合アザヘテロ環状化合物、及びａｍｐａ受容体調節因子としてのそれらの使用 |
| EA039344B1 (ru) * | 2017-01-19 | 2022-01-17 | Сучжоу Лонгбайотек Фармасьютикалз Ко., Лтд. | Гетероциклическое соединение в качестве ингибитора jak и его соли и терапевтическое применение |
| CN108341814B (zh) * | 2017-01-23 | 2021-09-03 | 上海翔锦生物科技有限公司 | Jak激酶抑制剂及其应用 |
| GB201702603D0 (en) | 2017-02-17 | 2017-04-05 | Galápagos Nv | Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| KR102874295B1 (ko) | 2017-02-17 | 2025-10-20 | 에이도스 테라퓨틱스, 인코포레이티드 | Ag-10, 이의 중간체, 및 이의 염을 제조하는 방법 |
| PL3595667T3 (pl) | 2017-03-14 | 2024-03-18 | Galapagos Nv | Kompozycje farmaceutyczne zawierające inhibitor jak |
| WO2018167283A1 (en) | 2017-03-17 | 2018-09-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma associated neural remodeling |
| WO2018189335A1 (en) | 2017-04-13 | 2018-10-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma |
| CN111479810B (zh) * | 2018-01-31 | 2022-11-22 | 珠海联邦制药股份有限公司 | Jak抑制剂及其应用 |
| PL3759109T3 (pl) | 2018-02-26 | 2024-03-04 | Gilead Sciences, Inc. | Podstawione związki pirolizyny jako inhibitory replikacji hbv |
| EP3758700B1 (en) | 2018-02-28 | 2024-07-31 | University of Southern California | Compositions for modulating inflammatory and degenerative disorders |
| US11058668B2 (en) | 2018-03-23 | 2021-07-13 | Eidos Therapeutics, Inc. | Methods of treating TTR amyloidosis using AG10 |
| GB201808575D0 (en) | 2018-05-24 | 2018-07-11 | Galapagos Nv | Methods for the treatment of psoriatic arthrits |
| IL325404A (en) | 2018-08-17 | 2026-02-01 | Eidos Therapeutics Inc | Spice formulations containing 3-(3-(5,3-dimethyl-1h-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid |
| KR102603729B1 (ko) * | 2018-08-23 | 2023-11-17 | 주하이 유나이티드 라보라토리즈 컴퍼니 리미티드 | Jak 억제제로서의 [1,2,4]트리아졸로[1,5-a]피리딘 화합물 및 이의 용도 |
| US10815227B2 (en) | 2018-08-27 | 2020-10-27 | Cadila Healthcare Limited | Processes for the preparation of filgotinib |
| WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
| WO2020097396A1 (en) | 2018-11-07 | 2020-05-14 | Dana-Farber Cancer Institute, Inc. | Benzimidazole derivatives and aza-benzimidazole derivatives as janus kinase 2 inhibitors and uses thereof |
| WO2020097398A1 (en) | 2018-11-07 | 2020-05-14 | Dana-Farber Cancer Institute, Inc. | Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof |
| EP3877371A4 (en) * | 2018-11-07 | 2022-07-27 | Dana-Farber Cancer Institute, Inc. | IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF |
| US11633399B2 (en) | 2018-12-25 | 2023-04-25 | Sol-Gel Technologies Ltd. | Treatment of skin disorders with compositions comprising an EGFR inhibitor |
| WO2021007477A1 (en) | 2019-07-11 | 2021-01-14 | E-Scape Bio, Inc. | Indazoles and azaindazoles as lrrk2 inhibitors |
| US20220274983A1 (en) * | 2019-08-06 | 2022-09-01 | Jiangsu Carephar Pharmaceutical Co., Ltd. | Jak kinase inhibitor and use thereof |
| US12214216B1 (en) | 2019-10-16 | 2025-02-04 | Helen Feng | Photon enhanced bone growth system and method |
| CN111072655B (zh) * | 2019-12-30 | 2021-12-10 | 深圳市坤健创新药物研究院 | 一种三氮唑并吡啶类化合物及其制备方法和药用组合物与应用 |
| KR102856998B1 (ko) * | 2020-02-13 | 2025-09-05 | 주하이 유나이티드 라보라토리즈 컴퍼니 리미티드 | Jak 키나아제 관련 질병의 치료를 위한 약물의 제조에 있어서 jak 억제제의 용도 |
| AU2021222686B2 (en) * | 2020-02-21 | 2023-06-29 | Zhuhai United Laboratories Co., Ltd. | Crystalline form of JAK inhibitor and application thereof |
| CA3181537A1 (en) | 2020-05-06 | 2021-11-11 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| CN111617318B (zh) * | 2020-05-26 | 2021-12-10 | 南京市儿童医院 | 可注射型儿童骺板再生水凝胶的制备方法 |
| CN114075188A (zh) * | 2020-08-11 | 2022-02-22 | 南京柯菲平盛辉制药有限公司 | 芳香杂环酰胺类化合物及其制备方法和医药用途 |
| CN114075189A (zh) * | 2020-08-11 | 2022-02-22 | 南京柯菲平盛辉制药有限公司 | 五元杂环并苯环类化合物及其制备方法和医药用途 |
| EP4267574B1 (en) | 2020-12-23 | 2025-04-23 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| CN114394965B (zh) * | 2021-01-29 | 2023-09-12 | 深圳市乐土生物医药有限公司 | 三唑并吡啶类化合物及其制备方法与用途 |
| TW202325289A (zh) | 2021-11-09 | 2023-07-01 | 美商雅捷可斯治療公司 | Ｊａｋ２抑制劑之形式及組合物 |
| JP7782035B2 (ja) | 2021-11-09 | 2025-12-08 | エイジャックス セラピューティクス， インコーポレイテッド | Ｊａｋ２阻害剤としての６－ヘテロアリールオキシベンゾイミダゾール及びアザベンゾイミダゾール |
| CN113773322B (zh) * | 2021-11-10 | 2022-02-11 | 奥锐特药业(天津)有限公司 | 一种Filgotinib的制备方法 |
| CN116354955A (zh) * | 2021-12-28 | 2023-06-30 | 上海科胜药物研发有限公司 | 一种菲戈替尼的制备方法 |
| CN116496268A (zh) * | 2022-01-18 | 2023-07-28 | 盛世泰科生物医药技术(苏州)有限公司 | 一种含环丙酰胺化合物及其应用 |
| US11596612B1 (en) | 2022-03-08 | 2023-03-07 | PTC Innovations, LLC | Topical anesthetics |
| US11746108B1 (en) * | 2022-06-13 | 2023-09-05 | Apm Therapeutics 1, Inc. | Triazolopyridine polymorph A |
| CN116687925B (zh) * | 2022-11-04 | 2024-10-22 | 中国科学院遗传与发育生物学研究所 | 一种侵蚀性蛋白酶抑制剂及其应用 |
| LU505465B1 (en) * | 2022-11-16 | 2024-05-14 | Adlai Nortye Biopharma Co Ltd | A pan-KRAS inhibitor compound |
| CN119462650B (zh) * | 2024-11-20 | 2025-10-17 | 沈阳药科大学 | 一种非戈替尼的合成方法 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000044722A1 (en) | 1999-01-29 | 2000-08-03 | Chugai Seiyaku Kabushiki Kaisha | Chondrongenesis promotors and indolin-2-one derivatives |
| US20040138285A1 (en) | 2001-04-27 | 2004-07-15 | Makoto Okazaki | Chondrogenesis promoters |
| US6514989B1 (en) * | 2001-07-20 | 2003-02-04 | Hoffmann-La Roche Inc. | Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives |
| CA2515190A1 (en) | 2003-02-14 | 2004-08-26 | Pfizer Products Inc. | Triazolo-pyridines as anti-inflammatory compounds |
| TWI221602B (en) * | 2003-07-21 | 2004-10-01 | Benq Corp | Emergent disc-withdrawing apparatus |
| US20050222171A1 (en) * | 2004-01-22 | 2005-10-06 | Guido Bold | Organic compounds |
| US20070004658A1 (en) | 2004-06-21 | 2007-01-04 | Nick Vandeghinste | Method and means for treatment of osteoarthritis |
| EP1786811A2 (en) | 2004-08-18 | 2007-05-23 | Pharmacia & Upjohn Company LLC | Triazolopyridine compounds |
| WO2006038116A2 (en) | 2004-10-07 | 2006-04-13 | Warner-Lambert Company Llc | Triazolopyridine derivatives as antibacterial agents |
| GB0515026D0 (en) * | 2005-07-21 | 2005-08-31 | Novartis Ag | Organic compounds |
| JP5336375B2 (ja) * | 2006-08-30 | 2013-11-06 | セルゾーム リミテッド | キナーゼ阻害剤としてのトリアゾール誘導体 |
| JP2010511018A (ja) * | 2006-12-01 | 2010-04-08 | ガラパゴス・ナムローゼ・フェンノートシャップ | 変性疾患及び炎症性疾患の治療に有用なトリアゾロピリジン化合物 |
| CL2008001626A1 (es) * | 2007-06-05 | 2009-06-05 | Takeda Pharmaceuticals Co | Compuestos derivados de heterociclos fusionados, agente farmaceutico que los comprende y su uso en la profilaxis y tratamiento del cancer. |
| US8053574B2 (en) * | 2007-07-18 | 2011-11-08 | Novartis Ag | Organic compounds |
| WO2009017954A1 (en) * | 2007-08-01 | 2009-02-05 | Phenomix Corporation | Inhibitors of jak2 kinase |
| CA2691448A1 (en) * | 2007-08-31 | 2009-03-05 | Dominique Swinnen | Triazolopyridine compounds and their use as ask inhibitors |
| GB0719803D0 (en) * | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| US8284682B2 (en) * | 2008-02-19 | 2012-10-09 | Qualcomm, Incorporated | Facilitating transfer of push and pull messages for remotely testing mobile devices |
| US20090217316A1 (en) * | 2008-02-22 | 2009-08-27 | Binita Gupta | Systems and Methods for Advertising Insertion Notification in a Real-Time Streaming Media Service |
| BRPI0909945A2 (pt) | 2008-06-20 | 2015-07-28 | Genentech Inc | "composto, composição farmacêutica, método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak2 quinase em um paciente, kit para o tratamento de uma doença ou distúrbio responsivo à inibição da jak quinase" |
| WO2010010189A1 (en) | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| WO2010010188A1 (en) | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases. |
| JO3041B1 (ar) * | 2008-07-25 | 2016-09-05 | Galapagos Nv | مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية |
| WO2010010184A1 (en) | 2008-07-25 | 2010-01-28 | Galapagos Nv | [1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors |
| WO2010010186A1 (en) | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| WO2010010187A1 (en) | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| DE102009000543A1 (de) * | 2009-02-02 | 2010-08-12 | Evonik Degussa Gmbh | Verfahren, Absorptionsmedien und Vorrichtung zur Absorption von CO2 aus Gasmischungen |
| PT2391435E (pt) * | 2009-02-02 | 2014-01-23 | Basf Se | Agente de absorção contendo aminas cíclicas para a remoção de gases ácidos |
| CN102459258B (zh) | 2009-06-05 | 2015-11-25 | 赛福伦公司 | 1,2,4-三唑并[1,5a]吡啶衍生物的制备和用途 |
| JO3030B1 (ar) | 2009-06-26 | 2016-09-05 | Galapagos Nv | مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات |
| TWI462920B (zh) | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| US20130310340A1 (en) | 2012-05-16 | 2013-11-21 | Rigel Pharmaceuticals, Inc. | Method of treating muscular degradation |
| AU2013279597B2 (en) | 2012-06-22 | 2017-04-20 | Alfasigma S.P.A. | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof |
-
2009
- 2009-07-12 JO JOP/2009/0259A patent/JO3041B1/ar active
- 2009-07-22 AR ARP090102793A patent/AR072875A1/es active IP Right Grant
- 2009-07-23 TW TW098124908A patent/TWI447118B/zh not_active IP Right Cessation
- 2009-07-23 CL CL2009001637A patent/CL2009001637A1/es unknown
- 2009-07-24 NZ NZ590646A patent/NZ590646A/en not_active IP Right Cessation
- 2009-07-24 ES ES09781073T patent/ES2406691T3/es active Active
- 2009-07-24 AU AU2009273144A patent/AU2009273144B2/en not_active Ceased
- 2009-07-24 KR KR1020117004384A patent/KR101676391B1/ko not_active Expired - Fee Related
- 2009-07-24 WO PCT/EP2009/059605 patent/WO2010010191A1/en not_active Ceased
- 2009-07-24 UY UY0001032006A patent/UY32006A/es active IP Right Grant
- 2009-07-24 CA CA2730762A patent/CA2730762C/en active Active
- 2009-07-24 BR BRPI0916659A patent/BRPI0916659B8/pt active IP Right Grant
- 2009-07-24 PE PE2009000989A patent/PE20100152A1/es active IP Right Grant
- 2009-07-24 MX MX2011000756A patent/MX2011000756A/es active IP Right Grant
- 2009-07-24 PL PL09781073T patent/PL2346864T3/pl unknown
- 2009-07-24 RS RS20130214A patent/RS52823B/sr unknown
- 2009-07-24 CA CA2730757A patent/CA2730757A1/en not_active Abandoned
- 2009-07-24 RS RS20140345A patent/RS53406B/sr unknown
- 2009-07-24 US US13/055,936 patent/US8853240B2/en active Active
- 2009-07-24 US US12/508,950 patent/US8242274B2/en active Active
- 2009-07-24 EA EA201170257A patent/EA018587B1/ru not_active IP Right Cessation
- 2009-07-24 MY MYPI20093101A patent/MY157615A/en unknown
- 2009-07-24 ES ES09781072.5T patent/ES2485913T3/es active Active
- 2009-07-24 DK DK09781072.5T patent/DK2361251T3/da active
- 2009-07-24 HR HRP20140681AT patent/HRP20140681T1/hr unknown
- 2009-07-24 BR BRPI0916862A patent/BRPI0916862B8/pt not_active IP Right Cessation
- 2009-07-24 KR KR1020117004383A patent/KR101711911B1/ko active Active
- 2009-07-24 JP JP2011519189A patent/JP5480261B2/ja active Active
- 2009-07-24 PL PL09781072T patent/PL2361251T3/pl unknown
- 2009-07-24 PT PT97810733T patent/PT2346864E/pt unknown
- 2009-07-24 HR HRP20130357AT patent/HRP20130357T1/hr unknown
- 2009-07-24 CN CN2009801291247A patent/CN102105472B/zh active Active
- 2009-07-24 ME MEP-2014-72A patent/ME02046B/me unknown
- 2009-07-24 WO PCT/EP2009/059604 patent/WO2010010190A1/en not_active Ceased
- 2009-07-24 MX MX2011000758A patent/MX2011000758A/es active IP Right Grant
- 2009-07-24 EA EA201170255A patent/EA018080B1/ru unknown
- 2009-07-24 SI SI200930973T patent/SI2361251T1/sl unknown
- 2009-07-24 SI SI200930582T patent/SI2346864T1/sl unknown
- 2009-07-24 EP EP09781072.5A patent/EP2361251B1/en active Active
- 2009-07-24 EP EP09781073A patent/EP2346864B1/en active Active
- 2009-07-24 JP JP2011519188A patent/JP5559168B2/ja active Active
- 2009-07-24 CN CN200980129088.4A patent/CN102105471B/zh active Active
- 2009-07-24 PT PT97810725T patent/PT2361251E/pt unknown
- 2009-07-24 DK DK09781073.3T patent/DK2346864T3/da active
- 2009-07-24 AU AU2009273143A patent/AU2009273143B2/en active Active
-
2010
- 2010-12-26 IL IL210261A patent/IL210261A/en active IP Right Grant
- 2010-12-26 IL IL210262A patent/IL210262A/en active IP Right Grant
-
2011
- 2011-01-14 ZA ZA2011/00396A patent/ZA201100396B/en unknown
- 2011-01-18 ZA ZA2011/00472A patent/ZA201100472B/en unknown
- 2011-01-18 DO DO2011000022A patent/DOP2011000022A/es unknown
- 2011-02-11 MA MA33602A patent/MA32551B1/fr unknown
- 2011-02-16 CR CR20110092A patent/CR20110092A/es unknown
- 2011-02-24 CO CO11022531A patent/CO6361925A2/es active IP Right Grant
-
2012
- 2012-08-10 US US13/572,043 patent/US20120309784A1/en not_active Abandoned
-
2013
- 2013-04-24 CY CY20131100335T patent/CY1113945T1/el unknown
- 2013-05-15 SM SM201300051T patent/SMT201300051B/xx unknown
-
2014
- 2014-06-17 SM SM201400072T patent/SMT201400072B/xx unknown
- 2014-07-29 CY CY20141100572T patent/CY1115569T1/el unknown
- 2014-10-06 US US14/507,396 patent/US9415037B2/en active Active
-
2016
- 2016-08-15 US US15/236,578 patent/US10206907B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011529033A5 (https=) | ||
| JP2011529032A5 (https=) | ||
| JP7604006B2 (ja) | Ａｓｈ１ｌ阻害剤及びそれを用いた治療方法 | |
| US10246464B2 (en) | Thienopyrimidine and thienopyridine compounds and methods of use thereof | |
| ES2826443T3 (es) | Inhibidores de proteínas mutantes KRAS G12C | |
| ES2987829T3 (es) | Compuestos heterocíclicos para obtención de imágenes y tratamiento del cáncer y métodos para su uso | |
| MX2009001534A (es) | Preparacion de (r,r)-fenoterol y analogos de (r,r)- o (r,s)-fenoterol y su uso en el tratamiento de insuficiencia cardiaca congestiva. | |
| CR20220609A (es) | Antagonistas del receptor de lpa y usos de los mismos | |
| CN111542318A (zh) | Ash1l降解剂及用其进行治疗的方法 | |
| MA33818B1 (fr) | Nouveaux antagonistes du récepteur ccr2 et leurs utilisations | |
| MX2011008799A (es) | Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados. | |
| TW200808314A (en) | Treatment of chemokine mediated diseases | |
| EA201000785A1 (ru) | Композиции для доставки в легкие | |
| NZ580009A (en) | Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer | |
| JP2016503765A5 (https=) | ||
| JP2016529218A5 (https=) | ||
| PH12012500826A1 (en) | Stable anti-tnfr1 polypeptides, antibody variable domains & antagonists | |
| JP2012509279A5 (https=) | ||
| Liu et al. | Functional and therapeutic significance of EZH2 in urological cancers | |
| US20230118233A1 (en) | Prc1 inhibitors and methods of treatment therewith | |
| JP2009541472A5 (https=) | ||
| MX2009007610A (es) | Heterociclicos biciclicos, medicamentos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion. | |
| JP2017536397A5 (https=) | ||
| JP2023533982A (ja) | Ｇａｓ４１阻害剤及びその使用方法 | |
| WO2008020269A3 (en) | A method of treating tumors with azaxanthones |